Omniab Inc Stock Market Value
OABIW Stock | USD 0.34 0.06 21.43% |
Symbol | OmniAb |
OmniAb Inc Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OmniAb. If investors know OmniAb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OmniAb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.202 | Quarterly Revenue Growth (0.24) | Return On Assets (0.14) | Return On Equity (0.20) |
The market value of OmniAb Inc is measured differently than its book value, which is the value of OmniAb that is recorded on the company's balance sheet. Investors also form their own opinion of OmniAb's value that differs from its market value or its book value, called intrinsic value, which is OmniAb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OmniAb's market value can be influenced by many factors that don't directly affect OmniAb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OmniAb's value and its price as these two are different measures arrived at by different means. Investors typically determine if OmniAb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OmniAb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
OmniAb 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to OmniAb's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of OmniAb.
10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in OmniAb on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding OmniAb Inc or generate 0.0% return on investment in OmniAb over 30 days. OmniAb is related to or competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. OmniAb is entity of United States. It is traded as Stock on NASDAQ exchange. More
OmniAb Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure OmniAb's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess OmniAb Inc upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 11.0 | |||
Information Ratio | 0.0223 | |||
Maximum Drawdown | 56.83 | |||
Value At Risk | (14.71) | |||
Potential Upside | 19.44 |
OmniAb Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for OmniAb's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as OmniAb's standard deviation. In reality, there are many statistical measures that can use OmniAb historical prices to predict the future OmniAb's volatility.Risk Adjusted Performance | 0.0357 | |||
Jensen Alpha | 0.1604 | |||
Total Risk Alpha | (1.26) | |||
Sortino Ratio | 0.021 | |||
Treynor Ratio | 0.2189 |
OmniAb Inc Backtested Returns
OmniAb Inc maintains Sharpe Ratio (i.e., Efficiency) of -0.0153, which implies the firm had a -0.0153% return per unit of risk over the last 3 months. OmniAb Inc exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check OmniAb's Risk Adjusted Performance of 0.0357, coefficient of variation of 2887.37, and Semi Deviation of 7.93 to confirm the risk estimate we provide. The company holds a Beta of 1.6, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, OmniAb will likely underperform. At this point, OmniAb Inc has a negative expected return of -0.15%. Please make sure to check OmniAb's maximum drawdown, as well as the relationship between the expected short fall and rate of daily change , to decide if OmniAb Inc performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.59 |
Good reverse predictability
OmniAb Inc has good reverse predictability. Overlapping area represents the amount of predictability between OmniAb time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of OmniAb Inc price movement. The serial correlation of -0.59 indicates that roughly 59.0% of current OmniAb price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.59 | |
Spearman Rank Test | -0.86 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
OmniAb Inc lagged returns against current returns
Autocorrelation, which is OmniAb stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting OmniAb's stock expected returns. We can calculate the autocorrelation of OmniAb returns to help us make a trade decision. For example, suppose you find that OmniAb has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
OmniAb regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If OmniAb stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if OmniAb stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in OmniAb stock over time.
Current vs Lagged Prices |
Timeline |
OmniAb Lagged Returns
When evaluating OmniAb's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of OmniAb stock have on its future price. OmniAb autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, OmniAb autocorrelation shows the relationship between OmniAb stock current value and its past values and can show if there is a momentum factor associated with investing in OmniAb Inc.
Regressed Prices |
Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for OmniAb Stock Analysis
When running OmniAb's price analysis, check to measure OmniAb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OmniAb is operating at the current time. Most of OmniAb's value examination focuses on studying past and present price action to predict the probability of OmniAb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OmniAb's price. Additionally, you may evaluate how the addition of OmniAb to your portfolios can decrease your overall portfolio volatility.